The 4 modules in this learning pathway provide a comprehensive update on current best practice as well as new and emerging therapies in AML, CLL, myelodysplastic disorders and myeloproliferative neoplasms. All modules are presented by leading Australian haematologists, who offer practical guidance and expert commentary on how advances in the diagnosis, prognostication and treatment of these diseases is shaping their management in Australian and internationally.
Description du cours
Détails du cours
Date d'expiration : 2021-03-31
Métiers: Spécialiste
Faculté
Dr Andrew Wei
MBBS, FRACP, FRCPA, PhD
Dr David Yeung
BSc (Med) MBBS (Hons) PhD FRACP FRCPA
Dr Melita Kenealy
MBBS (Hons) FRACP FRCPA
Dr Cecily Forsyth
MBBS (Hons) FRACP FRCPA
Accréditation
The National Advanced Haematology Trainee Program is endorsed by the Committee for Joint College Training in Haematology (CJCT), the Australasian Leukaemia & Lymphoma Group (ALLG) and the Haematology Society of Australia and New Zealand (HSANZ). The program is supported by independent educational grants provided by Platinum sponsor Amgen Australia, Gold sponsors Abbvie and Gilead Sciences, and Bronze sponsors Alexion, Roche Australia and Sanofi Genzyme.